Tag: Pancreatic

Popular

Molecule to Medicine: How Daraxonrasib is Rewriting Pancreatic Cancer Drug Development

Monash University’s Andrew R. Snyder, PhD. joins the show to discuss Daraxonrasib, a novel RAS(ON) inhibitor,…